Avery Kerry N L, Metcalfe Chris, Nicklin Joanna, Barham C Paul, Alderson Derek, Donovan Jenny L, Blazeby Jane M
Department of Social Medicine, University of Bristol, Canynge Hall, Whiteladies Road, Bristol Royal Infirmary, BS8 2PR, United Kingdom.
Ann Surg Oncol. 2006 Jun;13(6):817-22. doi: 10.1245/ASO.2006.08.019. Epub 2006 Apr 14.
Outcomes for treatment for upper gastrointestinal cancer traditionally include procedure-related morbidity and mortality and long-term survival. Patient-reported outcomes, such as quality of life (QOL) and satisfaction measures, add to standard end points, but associations between these factors are not fully understood. This study examined how patient satisfaction related to surgical morbidity, treatment type, and QOL outcomes after inpatient treatment for upper gastrointestinal cancer.
Consecutive patients who had completed treatment in one unit were invited to participate in this study and complete the European Organization for Research and Treatment of Cancer QLQ-PATSAT32 and QLQ-C30 questionnaires within 2 months of discharge. Regression analyses examined relationships between satisfaction and surgical morbidity (major complications and type of treatment) and between satisfaction and QOL variables, adjusting for age and sex.
During the study, 181 patients were treated, 162 were eligible, and 139 returned both questionnaires (response rate, 86%). Of the study sample, the treatment outcome was potential cure in 105 (67 esophagectomy and 38 D2 gastrectomy), and 34 received palliative treatment. Thirty-seven patients (27%) had major complications. Patients who received palliative treatment reported satisfaction and QOL scores similar to those of patients who received curative treatment. However, patients who experienced major morbidity reported significantly worse QOL than those without morbidity (P<.01). Satisfaction scores were the same in patients with or without complications. There were no associations between satisfaction and QOL scores (r<.34).
Patient satisfaction with hospital care is independent of morbidity, treatment type, and QOL outcomes. It may be used to feed back information to providers of health care to improve patients' experiences of treatment.
上消化道癌的治疗结果传统上包括与手术相关的发病率和死亡率以及长期生存率。患者报告的结果，如生活质量（QOL）和满意度测量，补充了标准终点，但这些因素之间的关联尚未完全了解。本研究探讨了上消化道癌住院治疗后患者满意度与手术发病率、治疗类型和生活质量结果之间的关系。
邀请在一个科室完成治疗的连续患者参与本研究，并在出院后2个月内完成欧洲癌症研究与治疗组织的QLQ - PATSAT32和QLQ - C30问卷。回归分析检查了满意度与手术发病率（主要并发症和治疗类型）之间以及满意度与生活质量变量之间的关系，并对年龄和性别进行了调整。
在研究期间，共治疗了181例患者，162例符合条件，139例返回了两份问卷（回复率为86%）。在研究样本中，105例（67例行食管切除术和38例行D2胃切除术）的治疗结果为可能治愈，34例接受了姑息治疗。37例患者（27%）出现主要并发症。接受姑息治疗的患者报告的满意度和生活质量得分与接受根治性治疗的患者相似。然而，发生严重并发症的患者报告的生活质量明显低于未发生并发症的患者（P<.01）。有或无并发症患者的满意度得分相同。满意度与生活质量得分之间无关联（r<.34）。
患者对医院护理的满意度与发病率、治疗类型和生活质量结果无关。它可用于向医疗保健提供者反馈信息，以改善患者的治疗体验。
